Maternal or Infant Antiretroviral Drugs to Reduce HIV-1 Transmission

Ahmed, Yusuf I.; Chasela, Charles S.; Chigwenembe, Maggie; Ellington, Sascha R.; Fiscus, Susan A.; Hoffman, Irving F.; Hosseinipour, Mina C.; Hudgens, Michael G.; Jamieson, Denise J.; Kacheche, Zebrone; Kamwendo, Deborah D.; Kayira, Dumbani; Kazembe, Peter; Knight, Rodney J.; Kourtis, Athena P.; Martinson, Francis; Mofolo, Innocent A.; Sichali, Dorothy S.; Soko, Alice; Tegha, Gerald; van der Horst, Charles M.; Wiener, Jeffrey B.

Maternal or Infant Antiretroviral Drugs to Reduce HIV-1 Transmission

Abstract

We evaluated the efficacy of a maternal triple-drug antiretroviral regimen or infant nevirapine prophylaxis for 28 weeks during breast-feeding to reduce postnatal transmission of human immunodeficiency virus type 1 (HIV-1) in Malawi

Similar works

Full text

Open in the Core reader

Download PDF

Available Versions

Carolina Digital Repository

cdr.lib.unc.edu:sf268d288

Last time updated on 24/11/2020